Teleflex Incorporated (NYSE:TFX) has been assigned an average rating of “Buy” from the eight brokerages that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold rating and six have given a buy rating to the company. The average 12 month target price among brokerages that have issued a report on the stock in the last year is $224.50.

Several research firms recently commented on TFX. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Needham & Company LLC reiterated a “buy” rating on shares of Teleflex in a research note on Friday. Zacks Investment Research upgraded Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective on the stock in a research note on Friday, June 23rd. Deutsche Bank AG upped their price objective on Teleflex from $213.00 to $220.00 and gave the company a “buy” rating in a research note on Monday, May 8th. Finally, Jefferies Group LLC restated a “buy” rating and set a $230.00 target price on shares of Teleflex in a research report on Thursday, August 3rd.

In other news, Director Stuart A. Randle sold 2,500 shares of the firm’s stock in a transaction dated Wednesday, June 7th. The stock was sold at an average price of $205.67, for a total transaction of $514,175.00. Following the transaction, the director now directly owns 7,532 shares of the company’s stock, valued at $1,549,106.44. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction dated Thursday, June 1st. The stock was sold at an average price of $199.93, for a total transaction of $39,986.00. Following the sale, the director now owns 8,080 shares of the company’s stock, valued at $1,615,434.40. The disclosure for this sale can be found here. Insiders have sold 8,300 shares of company stock worth $1,643,975 over the last ninety days. Insiders own 2.39% of the company’s stock.

Several hedge funds have recently bought and sold shares of the company. Asset Planning Services Ltd. bought a new stake in shares of Teleflex during the first quarter valued at approximately $116,000. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in shares of Teleflex during the first quarter valued at approximately $155,000. OLD Mutual Customised Solutions Proprietary Ltd. raised its stake in shares of Teleflex by 200.0% in the first quarter. OLD Mutual Customised Solutions Proprietary Ltd. now owns 900 shares of the medical technology company’s stock valued at $174,000 after buying an additional 600 shares during the period. Campbell & CO Investment Adviser LLC bought a new stake in shares of Teleflex during the second quarter valued at approximately $200,000. Finally, Harvey Capital Management Inc. bought a new stake in shares of Teleflex during the second quarter valued at approximately $207,000. Institutional investors own 93.02% of the company’s stock.

Teleflex (NYSE TFX) opened at 214.60 on Monday. Teleflex has a 12 month low of $136.53 and a 12 month high of $216.77. The company’s 50-day moving average price is $207.61 and its 200 day moving average price is $195.00. The firm has a market capitalization of $9.65 billion, a PE ratio of 44.54 and a beta of 1.05.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.91 by $0.13. Teleflex had a return on equity of 16.12% and a net margin of 12.36%. The firm had revenue of $528.60 million for the quarter, compared to the consensus estimate of $518.98 million. During the same quarter in the previous year, the business earned $1.89 EPS. The company’s revenue was up 11.6% compared to the same quarter last year. On average, equities research analysts predict that Teleflex will post $8.25 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, September 15th. Investors of record on Tuesday, August 15th will be paid a $0.34 dividend. The ex-dividend date of this dividend is Friday, August 11th. This represents a $1.36 dividend on an annualized basis and a yield of 0.63%. Teleflex’s dividend payout ratio is presently 26.00%.

TRADEMARK VIOLATION NOTICE: “Teleflex Incorporated (NYSE:TFX) Given Average Rating of “Buy” by Analysts” was published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another domain, it was illegally stolen and reposted in violation of U.S. & international trademark & copyright legislation. The original version of this report can be accessed at https://www.thecerbatgem.com/2017/08/08/teleflex-incorporated-nysetfx-receives-223-00-consensus-price-target-from-analysts-updated-updated-updated.html.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Stock Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related stocks with our FREE daily email newsletter.